New York, 05 January 2011. DataTern, Inc. today announces it has settled five patent infringement lawsuits involving its U.S. Patents 6,101,502 and 5,937,402, generating total revenues of $1.125 million.
In 2010, DataTern signed a total of 10 licenses, generating total revenues of $2.750 million, of which $2.025 million was generated in the second half of the year.
As reported as part of Amphion's Interim results in September 2010, the flow and timing of license settlements was negatively impacted by the restructuring of the IP programme undertaken during the first half of the year. However, activity has since picked up and in October 2010 DataTern filed suit against an additional 14 companies, bringing the total number of claims outstanding to 19 following the settlements announced today.
DataTern Chairman, Richard Morgan, said, "We are confident in the quality of the patents owned by DataTern and believe that a very large number of corporations are using this technology and infringing our patents. Our primary goal remains to license this technology on terms that are fair to the users and in the process to obtain an adequate return on the investment made in the technology. We expect to see additional settlements over the next few months, and beyond.
"Since inception, DataTern has signed 29 licenses with companies from the financial, credit card, retail, leisure, healthcare, airline, e-commerce, and software industries for a total of about $16 million."
About DataTern, Inc.
DataTern owns and develops critical technology that provides next generation software solutions for its customers. DataTern's patented product offerings include ObjectSpark Technologies, which allow customers to develop their own customised data service layers, making the company's offerings valuable to most industries, including automotive, banking, chemical, communications, financial, government, healthcare, insurance, pharmaceutical, trading, and many others. Non-exclusive licenses for DataTern's technologies and patents are available on reasonable and non-discriminatory terms.
For licensing terms, please contact email@example.com.
On the web: www.datatern.com
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number that grows rapidly each year.
On the web: www.amphionplc.com